Allegis Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Allegis Investment Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,197	Closed	-$263K	–	276
2017 Q2	$263K	Sell	4,197 -2,217	-35%	-$133K	0.07%	210
2017 Q1	$377K	Sell	6,414 -1,990	-24%	-$116K	0.1%	180
2016 Q4	$471K	Buy	8,404 +2,028	+32%	+$117K	0.15%	149
2016 Q3	$393K	Sell	6,376 -117	-2%	-$7.66K	0.15%	149
2016 Q2	$409K	Buy	6,493 +86	+1%	+$5.41K	0.21%	131
2016 Q1	$385K	Buy	6,407 +2,155	+51%	+$132K	0.22%	134
2015 Q4	$298K	Buy	+4,252	New	+$301K	0.17%	140

Other funds holding PJP

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Allegis Investment Advisors's PJP Position: Q3 2017 in Review

Allegis Investment Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2017, closing a stake of 4,197 shares — an estimated $263K sold.

Allegis Investment Advisors first reported a position in PJP in Q4 2015 and held it in 7 quarters. The position peaked at $471K in Q4 2016. 90 funds tracked by Wall St. Rank hold PJP as of Q3 2017.

Allegis Investment Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
Allegis Investment Advisors sold 4,197 Invesco Pharmaceuticals ETF shares in Q3 2017, an estimated $263K.
Allegis Investment Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and held it in 7 quarters.
Allegis Investment Advisors's Invesco Pharmaceuticals ETF position peaked at $471K in Q4 2016.
90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2017.

Based on Allegis Investment Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.